caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578656005

Joshua RifkindMD

PRACTICEPHYSIOTHERAPY ASSOCIATES INCSee all providers at this practice →
Hematology-OncologyGlendale, AZI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
867
Unique beneficiaries
—
Total services
38,766
Distinct HCPCS
27
Medicare payment
$385K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 199 Hematology-Oncology providers in AZ — above median (cohort median 31,409).
REFERRAL NETWORK

Where Joshua Rifkind's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MARY HITCHCOCK MEMORIAL HOSPITAL1001,263
Michael Luck
Diagnostic Radiology · Houston, TX
37214
GEHR, GERALD24229
Robert Sprague
Diagnostic Radiology · Bedford, NH
2284
David Fontaine
Diagnostic Radiology · Bedford, NH
2078
Elizabeth Angelakis
Diagnostic Radiology · Bedford, NH
1986
Susanne Huberty
Nurse Practitioner · Manchester, NH
19193
Kremena Star
Pathology · Manchester, NH
1771
Christopher Eckel
Diagnostic Radiology · Bedford, NH
1459
JOSELOW, WANE1342
ST JOSEPH HOSPITAL OF NASHUA NH1361
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
542
Beneficiaries
—
Total drug cost
$503K
Distinct drugs
12
Brand share
55.5%
Top prescribed drugs
Apixaban186 claims
Rivaroxaban61 claims
Anastrozole54 claims
Dexamethasone53 claims
Prochlorperazine Maleate46 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
9.4
Cost
75.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
104
By payment type
Food and Beverage$3K